These include the genes IRF8, CTLA-4, SLAMF8 and others, which are downregulated in DCM as compared to controls–or theoretically vice versa since the controls receive immunosuppressive medication after their heart transplantation. The gene discussed is CTLA4; the disease is familial dilated cardiomyopathy.